Greenland Mines Ltd (GRML)
Greenland Mines Ltd is a NASDAQ-listed common stock issuer based in Charlotte, North Carolina. The company describes itself as operating in natural resources, with a focus on the exploration and development of the Skaergaard Project in Southeast Greenland. It is also involved in work on KLTO-202, a cell and gene therapy candidate being developed for amyotrophic lateral sclerosis. The company previously operated under the name Klotho Neurosciences, Inc. before changing its name to Greenland Mines Ltd in March 2026.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-GRML
|
$4.08
|
43.0% Upside
|
Undervalued
|
$110 3,759.6% Upside
|
Not available
|
Bargain
|
Weak
|
0.0%
|
November 13, 2026
|
0.2x
|
13.708 M
|
978.734 K
|
2.0%
|
82.6%
|
-5.1
|
66.8%
|
